These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 21049090)

  • 21. Pharmacokinetic bridging approach for developing biologics-delivery devices: a case study with a golimumab autoinjector.
    Xu Z; Marciniak SJ; Frederick B; Kim L; Zhuang Y; Davis HM; Zhou H
    Clin Ther; 2015 Feb; 37(2):427-38. PubMed ID: 25438720
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A multicenter, randomized, open-label, comparative, two-period crossover trial of preference, efficacy, and safety profiles of a prefilled, disposable pen and conventional vial/syringe for insulin injection in patients with type 1 or 2 diabetes mellitus.
    Korytkowski M; Bell D; Jacobsen C; Suwannasari R;
    Clin Ther; 2003 Nov; 25(11):2836-48. PubMed ID: 14693308
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pharmacokinetic Profile of Subcutaneous Testosterone Enanthate Delivered via a Novel, Prefilled Single-Use Autoinjector: A Phase II Study.
    Kaminetsky J; Jaffe JS; Swerdloff RS
    Sex Med; 2015 Dec; 3(4):269-79. PubMed ID: 26797061
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Human factors validation study of 3 mg sumatriptan autoinjector, for migraine patients.
    Brand-Schieber E; Munjal S; Kumar R; Andre AD; Valladao W; Ramirez M
    Med Devices (Auckl); 2016; 9():131-7. PubMed ID: 27313479
    [TBL] [Abstract][Full Text] [Related]  

  • 25. International Survey to Evaluate Current Options for Subcutaneous Injection of Methotrexate (MTX) and a New Button-Free MTX Autoinjector.
    Müller-Ladner U; Edwards CJ; Erkens A
    Patient Prefer Adherence; 2024; 18():579-590. PubMed ID: 38463400
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Clinical Evaluation of an Investigational 5 mL Wearable Injector in Healthy Human Subjects.
    Woodley WD; Yue W; Morel DR; Lainesse A; Pettis RJ; Bolick NG
    Clin Transl Sci; 2021 May; 14(3):859-869. PubMed ID: 33278331
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Usability of Prefilled Syringe and Autoinjector for SB4 (An Etanercept Biosimilar) in Patients with Rheumatoid Arthritis.
    Rho YH; Rychlewska-Hańczewska A; Śliwowska B; Kim TH
    Adv Ther; 2019 Sep; 36(9):2287-2295. PubMed ID: 31372961
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Summative Usability Evaluation of the SCTE-AI Device: A Novel Prefilled Autoinjector for Subcutaneous Testosterone Administration.
    Arora S; Moclair B; Murphy K; Jaffe JS; Kaminetsky JC
    J Sex Med; 2018 Dec; 15(12):1707-1715. PubMed ID: 30393104
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Patients' perceptions of subcutaneous delivery of darbepoetin alfa by autoinjector prefilled pen versus prefilled syringe: a randomized, crossover study.
    Lim WH; Chan D; Boudville N; Pellicano S; Herson H; Moody H; Hutchison B; Snedeker M; Dogra G
    Clin Ther; 2012 Sep; 34(9):1948-53. PubMed ID: 22902097
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Evaluation of Usability and Acceptance of a New Autoinjector Intended for Methotrexate Subcutaneous Self-Administration in the Management of Rheumatoid Arthritis.
    Hudry C; Lebrun A; Moura B; Zinovieva E; Backers O; Herman-Demars H
    Rheumatol Ther; 2017 Jun; 4(1):183-194. PubMed ID: 28243967
    [TBL] [Abstract][Full Text] [Related]  

  • 31. An evaluation of patient preference for an alternative insulin delivery system compared to standard vial and syringe.
    Stockl K; Ory C; Vanderplas A; Nicklasson L; Lyness W; Cobden D; Chang E
    Curr Med Res Opin; 2007 Jan; 23(1):133-46. PubMed ID: 17257475
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Novel cannula design improves large volume auto-injection rates for high viscosity solutions.
    Roberts BC; Rini C; Klug R; Sherman DB; Morel D; Pettis RJ
    Drug Deliv; 2022 Dec; 29(1):43-51. PubMed ID: 34962225
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Clinical Investigation of Large Volume Subcutaneous Delivery up to 25 mL for Lean and Non-Lean Subjects.
    Dang X; Shih H; Sharma R; Angwin-Kaerner DT; Lin K; Kapur S; Thyagarajapuram NR; Shi GH; Collins DS
    Pharm Res; 2024 Apr; 41(4):751-763. PubMed ID: 38443633
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Evaluation of performance, acceptance, and compliance of an auto-injector in healthy and rheumatoid arthritic subjects measured by a motion capture system.
    Xiao X; Li W; Clawson C; Karvani D; Sondag P; Hahn JK
    Patient Prefer Adherence; 2018; 12():515-526. PubMed ID: 29674844
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Tolerability of High-Volume Subcutaneous Injections of a Viscous Placebo Buffer: A Randomized, Crossover Study in Healthy Subjects.
    Dias C; Abosaleem B; Crispino C; Gao B; Shaywitz A
    AAPS PharmSciTech; 2015 Oct; 16(5):1101-7. PubMed ID: 25693652
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Bioequivalence of Canakinumab Injected Subcutaneously via an Autoinjector Device or a Prefilled Safety Syringe Device in Healthy Subjects.
    Anumolu SS; Lindgren S; Vemula J; Floch D; Reynolds C; Wallny HJ; Sun H
    Clin Pharmacol Drug Dev; 2018 Nov; 7(8):829-836. PubMed ID: 29676864
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Comparative device assessments: Humalog KwikPen compared with vial and syringe and FlexPen.
    Ignaut DA; Schwartz SL; Sarwat S; Murphy HL
    Diabetes Educ; 2009; 35(5):789-98. PubMed ID: 19783767
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A Phase I Study to Assess the Effect of Speed of Injection on Pain, Tolerability, and Pharmacokinetics After High-volume Subcutaneous Administration of Gantenerumab in Healthy Volunteers.
    Portron A; Jordan P; Draper K; Muenzer C; Dickerson D; van Iersel T; Hofmann C
    Clin Ther; 2020 Jan; 42(1):108-120.e1. PubMed ID: 31883703
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Ease of use and preference for a new disposable self-injection pen compared with a reusable pen for administering recombinant human growth hormone: A multicenter, 2-month, single-arm, open-label clinical trial in patient-caregiver dyads.
    Hey-Hadavi J; Pleil A; Deeb LC; Fuqua JS; Silverman LA; Reiner B; Newfield R; Rajicic N; Wajnrajch MP; Cara JF
    Clin Ther; 2010 Nov; 32(12):2036-47. PubMed ID: 21118739
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A phase 1, randomized, open-label, single-dose study to assess the relative bioavailability of a subcutaneous dose of FKB327 when administered using a prefilled syringe, a prefilled auto-injector, or a vial with disposable syringe in healthy subjects.
    Bush J; Kawakami K; Muniz R
    BMC Pharmacol Toxicol; 2019 Dec; 20(1):87. PubMed ID: 31888742
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.